hot-drinks-can-cause-cancer-risks

Hot Beverages Cancer Risk: What Primary Care Needs to Know


Key Takeaways

  • A large-scale study reveals that regularly consuming very hot beverages (above 60°C to 65°C) could triple the risk of developing oesophageal cancer due to repeated thermal injury.
  • The primary carcinogenic mechanism stems from physical scalding of the oesophageal lining, which causes chronic inflammation, rapid cell turnover, and increased vulnerability to mucosal damage.
  • Public health news often prompts an influx of patient inquiries at general practices, adding pressure to already busy primary care teams.
  • Deploying structured ARRS clinical pharmacists through The Medicines Management Team (TMMT) allows practices to deliver comprehensive preventive health advice and medication reviews without straining GP supervisory capacity.
  • Practical advice such as allowing hot tea or coffee to cool for four to five minutes or adding cold milk substantially reduces thermal trauma while reassuring concerned patients.

Introduction

Headlines reporting that drinking very hot beverages can triple the risk of developing oesophageal cancer have prompted widespread public discussion across the UK. A major prospective study by Papier et al. (2026), published in the International Journal of Cancer, evaluated prospective data from nearly 1 million UK adults across the Million Women Study and UK Biobank cohorts. The study provides robust evidence that the physical temperature at which hot drinks are consumed rather than the chemical composition of tea or coffee is a significant modifiable risk factor for specific upper gastrointestinal malignancies.

When public health research receives national media attention, general practices across the National Health Service (NHS) often experience a surge in patient enquiries regarding dietary habits, acid reflux symptoms, and swallowing concerns. For Practice Managers, Primary Care Network (PCN) Leads, and GP Partners, handling these enquiries alongside routine chronic disease management and acute lists requires clear clinical guidance and efficient workflow organisation.

The Science of Thermal Injury and Oesophageal Cancer Risk 

The study led by researchers at the University of Oxford analysed 977,282 middle-aged UK adults followed for an average of 11 to 14 years. By cross-referencing self-reported drink temperature preferences and daily consumption frequencies against centrally held NHS cancer registries, the researchers identified distinct risk patterns across oesophageal cancer subtypes.

The key findings from the International Journal of Cancer study include:

  • Three-Fold Increase in Squamous Cell Carcinoma (SCC): Participants who preferred their tea or coffee “very hot” had a 3.17-times higher risk of developing oesophageal squamous cell carcinoma compared to those who drank their beverages “warm”.
  • No Association with Adenocarcinoma: The study found no material link between beverage temperature and oesophageal adenocarcinoma, demonstrating that thermal damage specifically targets the squamous cells lining the upper two-thirds of the oesophagus.
  • Frequency Matters: Consuming six or more hot drinks per day was associated with a 71% higher risk of SCC compared to consuming fewer than six cups daily.
  • Preventable Population Fraction: Researchers estimated that approximately 14% of oesophageal SCC cases in the UK population could be prevented if individuals drinking “very hot” beverages shifted to “warm” or “hot” temperatures.

The physiological mechanism driving this association is thermal trauma. Repeated exposure to scalding liquids causes micro-thermal burns to the squamous epithelium. This recurrent cellular injury triggers localised inflammation and forces rapid tissue repair, increasing the likelihood of genetic copying errors during cell division while weakening the mucosal barrier against dietary carcinogens.

Technical Methodology and Research Community Perspectives 

From a methodological standpoint, the study employed multivariable Cox proportional hazards regression modelling to estimate hazard ratios while adjusting for potential confounders. Adjustments included detailed smoking status, cumulative pack-years, alcohol intake, body mass index (BMI), socioeconomic status, and total liquid intake volume. The robust statistical power derived from combining two prospective national cohorts minimises recall bias, as beverage preferences were documented years prior to cancer diagnoses.

The research community has welcomed the findings as the most definitive evidence to date regarding hot beverages cancer risk within Western populations. Commenting on the study, lead author Dr Keren Papier from Oxford Population Health noted that while earlier studies primarily focused on South American mate or Middle Eastern tea-drinking cultures, this study confirms that thermal injury operates identically in UK populations where tea and coffee are daily staples. Independent epidemiological commentators emphasise that while the relative risk multiplier is striking, the absolute risk of developing oesophageal SCC in the UK remains relatively low. Consequently, research bodies caution against alarmism, reinforcing that tea and coffee contain beneficial antioxidants; the public health goal is simply temperature moderation rather than beverage avoidance.

What Challenges GP Practices Face When Managing Public Health Advice and Pharmacy Roles 

When health stories highlight lifestyle risks, primary care teams are usually the first point of contact for concerned patients. Integrating routine preventive advice and upper gastrointestinal triage into daily general practice, however, presents several operational challenges:

  • Increased Consultation Demand: Patients experiencing mild dyspepsia, acid reflux, or minor swallowing awareness frequently seek GP appointments following news reports on hot beverages cancer risk.
  • GP Partner Supervisory Burden: Expanding the primary care workforce via the NHS Additional Roles Reimbursement Scheme (ARRS) provides crucial capacity, but managing clinical pharmacists in-house demands significant supervisory time from senior GP partners.
  • Inconsistent Triage Workflows: Differences in practice protocols for repeat prescribing, symptom triaging, and lifestyle counselling can create administrative friction across PCN member practices.
  • Recruitment and Staff Retention: High staff turnover among primary care pharmacy personnel leaves ARRS funding allocations underutilised and disrupts clinical governance.

Without a structured management framework, surgery leadership can find valuable clinical time absorbed by administrative oversight rather than direct patient care.

How TMMT Supports Practices Operationally and Clinically 

To assist surgeries in maintaining clinical capacity while managing preventive health advice and prescribing governance, The Medicines Management Team (TMMT) provides specialised medicines management services. TMMT supplies embedded ARRS clinical pharmacists and pharmacy technicians working within a fully managed operational framework. 

Operating under an ISO 9001-certified Quality Management System, TMMT handles credentialing, line management, clinical supervision, and continuous peer audits. Connecting securely via NHS IT systems, TMMT remote clinical pharmacists absorb routine prescription reauthorisations, hospital discharge reconciliations, and symptom triaging, ensuring general practices maximise their ARRS reimbursement without burdening senior prescribers. 

Delivering Proactive Health Advice and Safeguarding Primary Care Capacity 

Addressing patient concerns around hot beverages cancer risk highlights the importance of proactive primary care messaging. By combining NHS ARRS workforce funding with established operational support, general practices and PCNs can deliver evidence-based lifestyle advice, protect senior prescribers from administrative strain, and maintain consistent standards of clinical quality.

Practice Managers, PCN Leads, and GP Partners looking to optimise their pharmacy capacity and unburden their clinical teams are invited to explore flexible operational support options with The Medicines Management Team.

Frequently Asked Questions

What did the 2026 study find regarding hot beverages cancer risk?

The prospective study of nearly 1 million UK adults (Papier et al., 2026) found that drinking “very hot” tea or coffee was associated with a 3.17-times higher risk of oesophageal squamous cell carcinoma compared to drinking “warm” beverages.

Does hot tea or coffee cause all types of oesophageal cancer?

No. The study found a strong association specifically with oesophageal squamous cell carcinoma (SCC), which affects the squamous cells lining the upper food pipe. There was no material association found with oesophageal adenocarcinoma.

How can patients reduce their risk without giving up hot drinks?

Patients can lower their risk by allowing freshly brewed tea or coffee to cool for four to five minutes before drinking, or by adding a splash of cold milk to drop the temperature below the harmful thermal threshold.

What red-flag symptoms require an urgent GP referral?

Patients presenting with progressive difficulty swallowing (dysphagia), painful swallowing (odynophagia), persistent acid reflux unresponsive to treatment, unexplained weight loss, or persistent hoarseness should be evaluated urgently by a clinician.

How do ARRS clinical pharmacists support GP practice workload management?

ARRS clinical pharmacists manage high-volume tasks including Structured Medication Reviews, repeat prescription reauthorisations, hospital discharge reconciliations, and routine lifestyle consultations, freeing up GP appointment capacity for complex patients

Do GP practices remain legally accountable when using remote clinical pharmacists?

Yes. General practices retain overall legal responsibility for patient care under CQC standards. Partnering with an ISO 9001-accredited provider ensures that all remote pharmacy workflows, clinical documentation, and safety audits strictly adhere to regulatory standards.

Author

  • Director, The Medicines Management Team

    Mohammed Rashad is a pharmacist and Director at The Medicines Management Team (TMMT), an award-winning provider of pharmacy services supporting over 85 Primary Care Networks (PCNs) and 250 GP practices across the UK. He works at scale with practices and PCNs to reduce workload, improve access, and deliver key targets such as QOF. Mohammed combines clinical expertise with strategic leadership to redesign how primary care operates. He leads on digital innovation, implementing performance dashboards, optimising workflows, and using data to drive smarter decisions. His work focuses on building scalable, high-performing models that deliver measurable impact. He regularly shares practical insights on improving efficiency, workforce productivity, and patient outcomes across primary care.

Related Blogs